Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent to Acquire Assets from ABC Instrumentación Analítica

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
The companies have signed a definitive agreement for Agilent to acquire assets from the privately held Mexican distributor.

The acquisition is expected to be completed on October 1, subject to customary closing conditions. Financial details were not disclosed.

Once the acquisition is final, former ABCIA customers in Mexico can look forward to an integrated sales and service portfolio directly from Agilent.

ABCIA was established in 1986 as a distributor of Hewlett-Packard Company's analytical solutions. ABCIA became an Agilent distributor when HP spun off Agilent in 1999. ABCIA provides sales, application support and customer training for Agilent products such as gas and liquid chromatographs, mass spectrometers, atomic and molecular spectroscopy systems, and bioanalyzers.

"Agilent and ABCIA have had a strong partnership for more than two decades," said Sylvia Escobar, vice president in charge of field operations for Agilent's chemical analysis business in the Americas. "As a unified team, we will provide a better customer experience by streamlining processes and delivering top-tier service in a consistent way. This acquisition also supports Agilent's aim to expand in the growing Mexican analytical market."

"We have worked successfully with Agilent for many years, and see this acquisition as a natural fit for both parties," said César Espinoza, CEO and founder of ABCIA. "We are pleased with the acquisition as it provides the opportunity to further enhance our long partnership with Agilent and solidify the brand's presence in the expanding Mexican market. The unification of our teams also provides our employees with a major opportunity for further professional development while ensuring that our clients will receive even better service."

About 30 ABCIA employees are expected to transfer to Agilent when the acquisition is final.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Presents Thought Leader Award to Renowned Medicinal Scientist
Company has announced that Dr. Shilin Chen has received an Agilent Thought Leader Award in support of his groundbreaking herbal genomics research using multi-omics techniques.
Saturday, April 30, 2016
Agilent Technologies Introduces First Commercial Software
Company has introduced new software to help cancer researchers in metabolic flux analysis.
Tuesday, April 19, 2016
Agilent, ASI Announce Agreement
Company has announced co-marketing agreement with ASI for fluorescence in situ hybridization.
Friday, April 08, 2016
Agilent Technologies and Eurofins Genomics Collaborate
Company has announced collaboration with Eurofins Genomics to expand SureVector cloning system.
Tuesday, March 22, 2016
Agilent Technologies to Sponsor USCAP 2016
Company has announced that it will be a Silver sponsor of USCAP 2016, the annual gathering of the United States and Canadian Academy of Pathology.
Thursday, March 10, 2016
Agilent Names CNAG as Certified Provider of Target-Enrichment Services
Centro Nacional de Análisis Genómico (CNAG) in Barcelona is one of Europe’s leading genome analysis centers.
Monday, February 23, 2015
Agilent to Close NMR Business
The announcement is part of Agilent's strategy to address the business shortfalls of its Research Products Division.
Wednesday, October 15, 2014
Agilent Technologies, University of Toronto to Collaborate on Metabolomics MRM Library-Software Solution
Scientists will be provided with a robust LC/MS solution to accelerate cell biology, disease research.
Tuesday, September 30, 2014
Agilent, Seoul National University to Collaborate on New Research Center
The facility will support new drug development center in the university's college of pharmacy.
Tuesday, May 13, 2014
Agilent Introduces Enhanced Electronic Laboratory Notebook
OpenLAB ELN integrates scientific results from multiple analytical software applications, quickly and easily.
Tuesday, November 19, 2013
Agilent and Daegu Gyeongbuk Institute of Science and Technology Collaborate
Neurometabolomics Center will use Agilent's bio-analytical instruments in research of biomarkers for early detection and diagnosis of brain diseases.
Friday, November 01, 2013
Agilent Combines Its Life Sciences and Diagnostics Businesses
Decision follows Agilent's announcement that it plans to separate the company into two independent publicly traded companies.
Thursday, September 19, 2013
Agilent Reports Third-Quarter Results
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Thursday, August 15, 2013
Agilent Technologies Triple Quadrupole ICP-MS Selected for R&D 100 Award
These prestigious awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
Monday, July 15, 2013
Agilent to Host Forensics Webinar
The webinar, which will be held on June 20, will focus on LC/MS/MS methods for cannabinoid and benzodiazepine quantitation in whole blood samples.
Wednesday, June 05, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!